Greig cephalopolysyndactyly syndrome
Greig cephalopolysyndactyly syndrome (GCPS) is a rare genetic disorder characterized by craniofacial abnormalities, polydactyly (extra fingers or toes), and syndactyly (webbing of fingers or toes). The syndrome is named after the Scottish physician David Middleton Greig, who first described the condition.
Presentation[edit]
Individuals with Greig cephalopolysyndactyly syndrome typically present with a combination of the following features:
- Macrocephaly (an abnormally large head)
- Hypertelorism (wide-set eyes)
- Polydactyly (extra digits on the hands and/or feet)
- Syndactyly (fusion of the fingers and/or toes)
- Developmental delay and intellectual disability in some cases
Genetics[edit]
GCPS is caused by mutations in the GLI3 gene, which plays a crucial role in the development of various body parts during embryogenesis. The condition follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit]
Diagnosis of Greig cephalopolysyndactyly syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the GLI3 gene. Prenatal diagnosis is possible if there is a known family history of the condition.
Management[edit]
There is no cure for GCPS, and treatment is symptomatic and supportive. Management may include:
- Surgical correction of polydactyly and syndactyly
- Early intervention programs for developmental delays
- Regular monitoring and supportive care for associated health issues
Epidemiology[edit]
Greig cephalopolysyndactyly syndrome is a rare condition, with its exact prevalence unknown. It affects both males and females equally.
See also[edit]
References[edit]
External links[edit]
-
| Medical Condition | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | N/A |
| Pronounce | N/A |
| Field | N/A |
| Symptoms | N/A |
| Complications | N/A |
| Onset | N/A |
| Duration | N/A |
| Types | N/A |
| Causes | N/A |
| Risks | N/A |
| Diagnosis | N/A |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | N/A |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | N/A |
| Deaths | N/A |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
